Drug Database
Back to search

Finland· FI-REL-REL5

Sembrina

A methyldopa (levorotatory) product containing methyldopa hydrate, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 10 of our 19 countries.

ATC C02AB01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSembrinaATCC02AB01REGISTER NO.FI-REL-REL5PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methyldopa hydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methyldopa (levorotatory) is registered in 10 of 19 countries.

Countries holding a registration under ATC C02AB01 (methyldopa (levorotatory)), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose
Search methyldopa (levorotatory) products by name

Methyldopa (levorotatory) · ATC C02AB01

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methyldopa (levorotatory) costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Methyldopa (levorotatory) · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • IT Italy$0.42
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Methyldopa hydrate
Manufacturer
Orion Corporation Orion Pharma
Country
Finland (FI)
ATC code
C02AB01
ATC class
Methyldopa (levorotatory)
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

182 interactions on record for methyldopa (levorotatory).

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methyldopa (levorotatory) against other medicinesHow interaction checks work

Methyldopa (levorotatory) · interactions on record

182 records

  • 8 severe
  • 95 moderate
  • 10 minor
  • 69 info

Most severe, free to view

  • ProcarbazineL01XB01severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • OzanimodL04AA38severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methyldopa (levorotatory) in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methyldopa (levorotatory) products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Aldometil
  • Belgium · Aldomet
  • Bulgaria · Допегит
  • Cyprus · Dopamet, Methyldopa Remedica
  • Czechia · Dopegyt
  • Germany · Dopegyt, Methyldopa Stada
  • Denmark · Methyldopa Macure
  • Spain · Aldomet, Aldomet Forte
  • France · Aldomet
  • United Kingdom (Northern Ireland) · Methyldopa, Methyldopa Accord-Uk
  • Hungary · Dopegyt
  • Italy · Aldomet
  • Lithuania · Dopegyt
  • Latvia · Dopegyt
  • Malta · Methyldopa Remedica
  • Netherlands · L-Methyldopa Teva, Methyldopa Cf
  • Norway · Methyldopa Macure
  • Poland · Dopegyt
  • Portugal · Aldomet, Aldomet Forte
  • Romania · Dopegyt
  • Sweden · Methyldopa Macure
  • Slovakia · Dopegyt

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4e747c8-5cfd-4b4b-a1d0-14add4b637e8
GET /v1/drugs/c4e747c8-5cfd-4b4b-a1d0-14add4b637e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "g",
  "strength": "250 mg",
  "atc_label": "metyylidopa (levomuoto)",
  "ma_number": "37",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL5",
  "authorised_at": "1964-08-26"
}
API referenceMCP serverPlans

See everything about methyldopa (levorotatory).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console